Damora Therapeutics Names Jennifer Jarrett CEO; Shares Rise After Leadership Shake-Up
Damora Therapeutics Inc announced the appointment of Jennifer Jarrett as President and Chief Executive Officer effective March 30, 2026, and disclosed several board changes including a new chairman. The leadership moves came alongside the completion of a transaction with Galecto and coincided with a 15.5% gain in the company’s shares.